Clinical Trials Supply

Clinical Trials
Pharmaceutical Supply
for Sponsors and CROs

Euro Biom is an MHRA WDA-licensed wholesale distributor sourcing Investigational Medicinal Products, comparator drugs, reference standards and ancillary trial supplies for pharmaceutical sponsors, contract research organisations and clinical research sites globally.

MHRA WDA Licence No. WDA(H) 59239Granted 17 March 2026
Submit a Trial Sourcing Brief Comparator Sourcing →

⚡ Same-day response to every brief  ·  Mon-Fri 09:00-18:00  ·  WhatsApp us

What We Supply for Clinical Trials
Investigational products,
comparators and ancillaries.

Euro Biom sources the medicinal products required across all phases of clinical research. From single-batch comparator orders for a Phase II study to ongoing IMP supply across a multi-country Phase III programme, we work with the precise specification, quantity and timeline you submit.

Our scope includes Investigational Medicinal Products under MHRA-authorised pathways, branded comparators and Reference Listed Drugs (RLDs) for active-control arms, reference standards for analytical work, and ancillary trial supplies such as rescue medications, standard-of-care drugs and supportive medications required by the protocol.

We do not act as the sponsor, manufacturer or contract packaging organisation. We are the licensed wholesale dealer that locates verified product, secures it, documents it to GDP standards and ships it to the trial site you nominate.

IMPs Comparators & RLDs Reference Standards Ancillary Supplies
"Trial supply fails when sourcing is treated as procurement. It succeeds when it is treated as a regulated, traceable, documented chain. That is what an MHRA WDA delivers."
Who We Serve
Sponsors, CROs and Clinical
Research Institutions

Clinical trial supply is a small, specialised market. The buyers and protocol stakeholders we work with most.

🧪
Pharma Sponsors
Pharmaceutical companies running their own trials, from biotech start-ups testing a single asset to mid-size sponsors managing portfolios across multiple therapeutic areas.
📋
Contract Research Organisations
CROs delivering full-service or functional sourcing on behalf of sponsors. We integrate with your supply lead, regulatory team and trial logistics workflow.
🎓
Academic Research Sites
University-led investigator-initiated trials and academic medical centres requiring small-volume, brand-specific comparators or hard-to-source reference products.
🏥
Hospital Trial Units
NHS Clinical Research Facilities and international hospital research units running early-phase studies and needing rapid, compliant access to specific medicinal products.
Regulatory Framework

The authorisations that
make trial supply defensible.

Clinical trial sourcing involves layered regulatory obligations. Euro Biom holds the wholesale licensing required and works within the trial-specific authorisations held by the sponsor or CRO.

MHRA Wholesale Dealer Authorisation

Euro Biom holds WDA(H) 59239, granted by the Medicines and Healthcare products Regulatory Agency on 17 March 2026. This authorisation covers procurement, supply and export of medicinal products including those used as IMPs and comparators. Publicly verifiable on the MHRA register.

WDA(H) 59239  |  MHRA Site 37434242

UK Good Distribution Practice

All clinical trial product is handled to UK GDP guidelines. This includes qualified personnel, documented quality system, validated cold chain, calibrated temperature monitoring, deviation management and full chain-of-custody records from authorised supplier through to delivery at the trial site.

GDP-compliant chain of custody on every shipment

UK and EU Clinical Trial Regulation Alignment

Sponsors and CROs hold the Clinical Trial Authorisations and operate under MHRA frameworks, EU Clinical Trials Regulation 536/2014 and, where applicable, US FDA IND requirements. Our role is to source and supply within those frameworks, ensuring documentation supports sponsor regulatory submissions and inspections.

Documentation aligned with sponsor regulatory needs

Manufacturing and Packaging Coordination

Where blinded supply, over-encapsulation, label translation or matched-placebo coordination is required, we work with MHRA MIA(IMP)-licensed packaging and manufacturing partners. Euro Biom remains the named wholesale supplier; the licensed manufacturer handles any physical reconfiguration of the product.

Licensed packaging partners for blinded trials
How It Works
From Sourcing Brief
to Trial Site Delivery

A four-step process designed for the documentation, traceability and timing demands of regulated clinical research.

Step 01
01
Feasibility and Specification
You send the protocol-driven specification: product, brand or RLD, strength, dosage form, batch and shelf-life requirements, quantity per site, total study volume and target dates. We confirm feasibility within the working day.
Step 02
02
Sourcing and Verification
We identify authorised manufacturers or licensed wholesalers, verify product provenance, confirm batch availability, secure expiry dating that meets your trial duration and provide written quotation with documentary evidence of the chain.
Step 03
03
Packaging and Labelling
Where the protocol requires blinded over-encapsulation, randomised kit assembly or trial-specific labelling, we coordinate with MHRA MIA(IMP)-licensed packaging partners. You retain control of randomisation schedules and label content.
Step 04
04
Distribution and Documentation
Product is shipped to nominated trial sites via specialist pharmaceutical logistics with continuous temperature monitoring, customs clearance for international destinations and complete documentation pack delivered alongside.
Therapeutic Areas We Cover
Trial Supply Across All
Major Research Categories

Comparator and IMP requirements arise across every therapeutic area. Euro Biom has supplied or quoted on trials in each of the following.

🔬
Oncology
Cytotoxics, targeted therapies, immuno-oncology comparators, supportive care drugs and rescue medications. Often the highest-volume comparator demand in active research.
🧬
Rare and Orphan Disease
Specialist sourcing for low-volume, often hard-to-locate products in rare disease trials including enzyme replacement therapies and orphan-indication medicines.
💉
Biologics and Biosimilars
Monoclonal antibodies, fusion proteins, biosimilar comparators and reference biologics. Cold-chain and batch-matching considerations are central to specification.
🫀
Cardiovascular
Anticoagulants, anti-arrhythmics, antihypertensives and lipid-modifying therapies frequently used as active controls in cardiovascular outcomes trials.
👶
Paediatric Trials
Age-appropriate formulations, paediatric strengths and specialist liquid formulations including products subject to PIP requirements and EMA paediatric obligations.
🧠
CNS and Neurology
Antipsychotics, antidepressants, antiepileptics, MS disease-modifying therapies and Parkinson's medications used as active comparators in neuroscience trials.
Cold Chain Capability
Validated temperature
control across every tier.

Modern clinical trial portfolios increasingly involve biologics, cell therapies and gene therapies with strict temperature requirements. We coordinate validated cold-chain handling across the full range, with calibrated monitoring on every shipment.

Temperature deviations are flagged immediately. Any excursion outside the validated range is documented, escalated and product is quarantined pending sponsor review. No untested product reaches a trial site.

Learn more about cold-chain capability →
+15°
+25°
Controlled Room Temperature
Standard storage and shipping for ambient-stable IMPs, oral solid dose comparators and small-molecule reference standards. Continuous monitoring through transit.
+2°
+8°
Refrigerated
Validated 2 to 8 degrees Celsius transport for biologics, vaccines, monoclonal antibody comparators and refrigerated reference standards. Calibrated data loggers on every consignment.
-20°
Frozen
Minus 20 degrees Celsius handling for frozen biologics, certain reference standards and protocol-specified frozen products. Validated containers with deviation alerts.
-80°
Ultra-Cold and Cryogenic
Dry-ice and liquid nitrogen handling for cell therapy IMPs, gene therapy products and ultra-cold biologics. Coordinated through specialist GDP-licensed logistics partners.

Submit a Clinical Trial Sourcing Brief

Send us the protocol specification. We assess feasibility, identify sourcing routes and respond the same working day with options, indicative timelines and documentary evidence.

Frequently Asked Questions
Clinical Trials Supply, Explained

Common questions from sponsor supply leads, CRO sourcing managers and clinical research investigators.

What is an Investigational Medicinal Product (IMP)?
An IMP is a pharmaceutical form of an active ingredient or placebo being tested or used as a reference in a clinical trial, including products with a marketing authorisation when used in a way different from the authorised form. IMPs must be supplied through MHRA-authorised channels.
How quickly can you source comparator drugs?
For commonly stocked branded comparators, supply is typically arranged within 2 to 4 weeks of confirmed brief. For complex requirements such as discontinued brands or specific batch matching, we provide an honest indicative timeline at the feasibility stage. Same-day response on every brief.
Do you supply blinded or randomised trial kits?
Yes, through coordination with MHRA MIA(IMP)-licensed packaging partners. Blinded over-encapsulation, matched-placebo coordination and randomised kit assembly are arranged through licensed manufacturing facilities. Euro Biom sources, documents and ships; the licensed packager handles physical reconfiguration.
Which regulatory frameworks apply to your trial supply?
MHRA WDA(H) 59239, UK GDP, Human Medicines Regulations 2012. Sponsors and CROs hold their own Clinical Trial Authorisations under MHRA frameworks, EU CTR 536/2014 and US FDA IND requirements where relevant. We supply within those frameworks; we do not act as the sponsor.
Can you supply IMPs and comparators globally?
Yes. We source from the UK and EU and ship to trial sites worldwide via Heathrow logistics. Past supply has covered Europe, Middle East, Africa and Asia. We manage UK export documentation, customs paperwork, GDP cold chain and chain of custody.
What documentation comes with each shipment?
Certificate of Analysis, manufacturer batch records, full chain of custody, temperature monitoring data where required, packing lists, customs paperwork and country-specific import documentation. Structured to support sponsor and CRO regulatory inspections.
Can you handle ultra-cold chain for cell and gene therapies?
Yes. Through GDP-licensed specialist logistics partners we coordinate 2 to 8 degrees, minus 20, dry ice and liquid nitrogen handling for cell and gene therapy IMPs. Continuous calibrated monitoring with excursion alerts. Any deviation is flagged immediately for sponsor review.